Clinical Trial: (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Uveal Melanoma
Study Type: INTERVENTIONAL
Official Title: (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Brief Summary:
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma
Read more